ESR1 and Alzheimer disease: According to the target distribution of potential effective constituents in XXMD, the inflammatory reaction and cholinergic system were the main pathways which XXMD affect, and COX-2, ERα and AChE were the major targets of constituents in XXMD linked to the potential treatment of AD.